Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

CDx Partners with AZ Med Testing to Expand the MyDx Analyzer Platform
  • USA - English


News provided by

CDx, Inc.

Feb 07, 2014, 21:00 ET

Share this article

Share toX

Share this article

Share toX

MyDx Cannabis App
MyDx Cannabis App

La Jolla, CA (PRWEB) February 07, 2014 -- With just over 40 days left in the indiegogo campaign, MyDx draws nearer to its first funding goal. With everyone's continued support, we believe we can meet all of our goals and exceed expectations.

CDx advances forward towards legitimacy and accessibility to patients.

Post this

Since our campaign launch, we have been gratefully overwhelmed with support and interest in our revolutionary device. With so much positive feedback, legitimate questions and concerns have also emerged in forums and discussions everywhere about whether the MyDx analyzer can deliver trusted results. How can such an affordable device compete with expensive lab quality results? The answer is simple: technology.

By utilizing state of the art electronic nose technology used by NASA, we are able to take something that would normally be large and make it small, yet similarly functional. Don't just take our word for it though. We've teamed up with AZ Med Testing, a cannabis testing laboratory featured in USA Today, who has more than 53 years of combined lab, analysis and environmental testing experience. CDx and AZ Med are collaborating to use the MyDx analyzer platform side by side with in house laboratory equipment to compare data and ensure the results of the MyDx Analyzer are in line with laboratory standards. This is only the beginning of our commitment to quality. AZ Med Testing and MyDx have stepped it up even further, and are committed to being recognized by the international community by seeking ISO certification. Our motto is to trust and verify what you put into your mind and body, and we are certain you will be able to trust and verify MyDx.

The MyDx Cannabis App

The final update to our campaign this week is our new perk. With so many cannabis strains on the market, it's no secret that finding the correct strain can become a daunting task. In an effort to solve this problem, patients will soon be able to use the MyDx Android or iOS Application even before the MyDx analyzer is ready to test their samples. By simply entering a sample ID provided by laboratories that meet third party approved standards of accuracy and compliance, such as AZ Med Testing, or by manually entering the chemical composition of their already tested cannabis samples, patients will be able to start tracking how specific cannabinoid/terpenoid profiles are making them feel. The MyDx application will then be able to make personalized recommendations, suggesting cannabis products exclusively based on individual data and requirements versus the data of a collective survey. Since everyone has a unique body chemistry, it's no surprise how essential the MyDx application can be in improving your personal cannabis experience.

Patients will also have the option to share their data anonymously in a public database that will be managed by CDx and it's central lab partners. This option is part of our commitment and belief that the MyDx application is as much about privacy as it is about your choice to help the public. Patients that decide to contribute to this database can expect that their data will play a vital role in equipping patients and industry professionals with the knowledge they need to make informed decisions. Doctors will finally be able to analyze and interpret up to date patient data which would result in more precise recommendations on dosage, intake methods, and cannabinoid/terpenoid profiles. Patients and doctors will no longer have to only rely on strain name recommendations and in store suggestions. They will finally know what to expect from their medication, promising a more pleasant and relieving cannabis experience.

Our vision of an empowered consumer draws ever closer and we need your continued support like never before! Share our campaign and help our vision of a healthier world become a reality.

Thank you.

Related Links:
http://www.indiegogo.com/projects/mydx
http://azmedtest.com/

###
About CDx
CDx, Inc. was founded on the mission of empowering people to live healthier lives by understanding the purity of everything they eat, drink, and inhale. MyDx - A Device for a Better Life, is their first product, and will work with interchangeable sensors to test for pesticides in food, chemicals in water, toxins in air, and the safety and potency of cannabis samples. While CDx plans to ship MyDx globally, the team has made a strategic decision not ship the cannabis sensor to consumers in states that have not legalized the adult possession and consumption of cannabis either medically or recreationally. However, the MyDx App and all other sensors will be available without restriction.

About AZ Med Testing
AZ Med Testing is a pioneer in the new and emerging Arizona medicinal cannabis testing market. Through proven scientific methodology, AZ Med will guarantee the quality of medicine dispensed as well as proper dosing. Their medical marijuana testing lab is located in Phoenix, Arizona and their state-of-the-art facility and equipment offer medicinal cannabis testing for dispensaries, caregivers, and patients.

Karina Smith - Media Relations, CDx, Inc., http://www.indiegogo.com/projects/mydx, +1 800.814.4550, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.